-6.3 C
New York
Monday, January 26, 2026

Global News

Millions celebrate national day in Australia as heatwave warnings issued

Australian authorities have issued heatwave warnings for most of the country as millions celebrate Australia Day.Temperatures are expected to peak on Tuesday, reaching the...

Travel Guides

Sports

Taylor Clements, a finalist in the Winter Juniors ‘A’ division, commits to West Virginia for the 2026-27 season.

Fitter and Faster Swim Camps is the proud sponsor of SwimSwam’s College Recruiting Channel and all commitment news. For many, swimming in college is...

innovation

Human trials begin for new CRISPR therapy to reduce cholesterol

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If successful, it could be the...

Most Popular

Fitness

Video: Minneapolis holds Anti-ICE protest following the second death of a US citizen | Police

NewsFeedHundreds of protesters marched in the US city of Minneapolis on Sunday, demanding justice for the fatal ICE shooting that killed US citizen Alex...

US interest rate analysis poses a significant challenge for coordinated yen intervention efforts

Analysis-US rate check masks stiff hurdle to coordinated yen intervention

Millions celebrate national day in Australia as heatwave warnings issued

Australian authorities have issued heatwave warnings for most of the country as millions celebrate Australia Day.Temperatures are expected to peak on Tuesday, reaching the...

Icon of a Downward Arrow Button

 Canadian Prime Minister Mark Carney said Sunday his country has no intention of pursuing a free trade deal with China. He was responding to U.S. President...

Taylor Clements, a finalist in the Winter Juniors ‘A’ division, commits to West Virginia for the 2026-27 season.

Fitter and Faster Swim Camps is the proud sponsor of SwimSwam’s College Recruiting Channel and all commitment news. For many, swimming in college is...

Top

Human trials begin for new CRISPR therapy to reduce cholesterol

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If successful, it could be the...

Latest Articles

Must Read